23 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, including a principal of accountability and the obligation to demonstrate compliance through policies, procedures, training and audit. In addition, some … among different CROs and trial sites;
delays in identifying, recruiting and training suitable clinical investigators;
obtaining approval or positive
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
annually, or for employees will arrange for certification via the Company’s online training system (if applicable).
* * * * *
Effective Version
Description
F-1/A
6phb97o27cwe
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
x7krjkt1mq5
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
6-K
f4qvmkc6sfn
16 Jul 19
Current report (foreign)
8:21am
20-F
df4nl1nhppqg8
29 Apr 19
Annual report (foreign)
4:59pm
424B3
op0mcekwzm0p
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
l1ihat x7
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
5f11rlstiq08oi
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.10
isa7ay6q 90t9
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.12
9n8 b6cashqn
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.11
pa7j6w6lhju lmq0
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.9
k4roi3aun8 hf58n9
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.22
dtdlkmyj0 gn
25 Jan 19
Registration of securities (foreign)
12:00am